United Therapeutics Corporation (UTHR): Price and Financial Metrics
UTHR Price/Volume Stats
| Current price | $364.33 | 52-week high | $417.82 |
| Prev. close | $360.71 | 52-week low | $208.62 |
| Day low | $359.40 | Volume | 199,200 |
| Day high | $365.67 | Avg. volume | 461,020 |
| 50-day MA | $363.86 | Dividend yield | N/A |
| 200-day MA | $300.92 | Market Cap | 16.27B |
UTHR Stock Price Chart Interactive Chart >
United Therapeutics Corporation (UTHR) Company Bio
United Therapeutics develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. Its lead product comprises Remodulin, an injection used for the treatment of pulmonary arterial hypertension. The company was founded in 1996 and is based in Silver Spring, Maryland.
UTHR Price Returns
| 1-mo | -1.60% |
| 3-mo | 4.68% |
| 6-mo | 33.51% |
| 1-year | 58.07% |
| 3-year | 83.16% |
| 5-year | 291.71% |
| YTD | 65.69% |
| 2023 | -20.93% |
| 2022 | 28.70% |
| 2021 | 42.35% |
| 2020 | 72.33% |
| 2019 | -19.12% |
Continue Researching UTHR
Want to see what other sources are saying about UNITED THERAPEUTICS Corp's financials and stock price? Try the links below:UNITED THERAPEUTICS Corp (UTHR) Stock Price | Nasdaq
UNITED THERAPEUTICS Corp (UTHR) Stock Quote, History and News - Yahoo Finance
UNITED THERAPEUTICS Corp (UTHR) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...